ClinicalTrials.gov
public full text
Public Domain
Pharmacometabolomic of Trabectedin in Soft Tissue Patients
This perspective, mono institutional study is addressed to find potential serum and urine biomarkers predictive of the pharmacokinetic and pharmacodynamic profile of soft tissue sarcomas patients treated with trabectedin.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Multidrug Resistance After Trabeculectomy With Mitomycin C#914022
- Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas#879615
- Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice#676802
- Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy#876036
- Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients#904657
Record · ID 839552
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive